Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan W Day

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
A Phase 1 and Biodistribution study of Ifabotuzumab, a humanized agonistic EphA3-targeted antibody, in patients with recurrent glioblastomaHui K Gan, Lawrence Cher, Po-Ling Inglis, et al.
BMJ Open|May 15, 2023
LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot studyBenjamin Y Kong, Hao-Wen Sim, Anna K Nowak, et al.
Acta Neuropathologica|August 30, 2019
The dystroglycan receptor maintains glioma stem cells in the vascular nicheBryan W Day, Justin D Lathia, Zara C Bruce, et al.
Neuro-Oncology|September 11, 2019
Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophoreYi Chieh Lim, Kathleen S Ensbey, Carolin Offenhäuser, et al.
Nature Communications|February 5, 2025
Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179Yuchen Li, Chaemin Lim, Taylor Dismuke, et al.
Research Square|June 19, 2023
Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179Yuchen Li, Chaemin Lim, Taylor Dismuke, et al.
Cell Reports. Medicine|March 25, 2026
Early-stage multi-cancer detection through a plasma extracellular vesicle protein signatureRichard J Lobb, Quan Zhou, David Fielding, et al.
Nature Communications|December 15, 2025
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastomaGeorge L Joun, Emma G Kempe, Brianna Chen, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
A Phase 1 and Biodistribution study of Ifabotuzumab, a humanized agonistic EphA3-targeted antibody, in patients with recurrent glioblastomaHui K Gan, Lawrence Cher, Po-Ling Inglis, et al.
BMJ Open|May 15, 2023
LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot studyBenjamin Y Kong, Hao-Wen Sim, Anna K Nowak, et al.
Acta Neuropathologica|August 30, 2019
The dystroglycan receptor maintains glioma stem cells in the vascular nicheBryan W Day, Justin D Lathia, Zara C Bruce, et al.
Neuro-Oncology|September 11, 2019
Simultaneous targeting of DNA replication and homologous recombination in glioblastoma with a polyether ionophoreYi Chieh Lim, Kathleen S Ensbey, Carolin Offenhäuser, et al.
Nature Communications|February 5, 2025
Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179Yuchen Li, Chaemin Lim, Taylor Dismuke, et al.
Research Square|June 19, 2023
Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179Yuchen Li, Chaemin Lim, Taylor Dismuke, et al.
Cell Reports. Medicine|March 25, 2026
Early-stage multi-cancer detection through a plasma extracellular vesicle protein signatureRichard J Lobb, Quan Zhou, David Fielding, et al.
Nature Communications|December 15, 2025
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastomaGeorge L Joun, Emma G Kempe, Brianna Chen, et al.
Pageof 8